<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Indian J Med Res</journal-id>
      <journal-id journal-id-type="iso-abbrev">Indian J. Med. Res</journal-id>
      <journal-id journal-id-type="publisher-id">IJMR</journal-id>
      <journal-title-group>
        <journal-title>The Indian Journal of Medical Research</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0971-5916</issn>
      <issn pub-type="epub">0975-9174</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23760391</article-id>
      <article-id pub-id-type="pmc">3734697</article-id>
      <article-id pub-id-type="publisher-id">IJMR-137-993</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Clinical Image</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Central pontine myelinolysis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Khosya</surname>
            <given-names>Surendra</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
          <xref ref-type="corresp" rid="cor1">+</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meena</surname>
            <given-names>Hariom</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">**</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>*</label>Department of General Medicine, Govt Medical College, Kota, India</aff>
      <aff id="aff2"><label>**</label>Department of General Medicine, Maharaja Agrasen Medical College, Agroha, Haryana, India</aff>
      <author-notes>
        <corresp id="cor1"><label>+</label><italic>For correspondence</italic>: Shyam Tent House Bus Stand Manoharpur Shahpura Jaipur 303 104, India <email xlink:href="drkhosya3@gmail.com">drkhosya3@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2013</year>
      </pub-date>
      <volume>137</volume>
      <issue>5</issue>
      <fpage>993</fpage>
      <lpage>994</lpage>
      <permissions>
        <copyright-statement>Copyright: &#xA9; The Indian Journal of Medical Research</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>A 58-year old man presented to M.B.S Hospital, Government Medical College, Kota, Rajasthan, with non-projectile vomiting and watery diarrhoea for the last three days. On admission, his initial blood tests were within normal range except for severe hyponatremia with a sodium level of 100 mmol/l (normal, 135-145 mmol/l). Normal saline was administered intravenously, and the sodium level began to normalize at 100, 106, 122 and 130 mmol/l on days 2, 3, 5 and 7, respectively. One week later, he had complaints of difficulty in swallowing and speaking accompanied by unsteadiness of gait and eventual inability to walk. Initial magnetic resonance imaging (MRI) (<xref ref-type="fig" rid="F1">Fig. 1</xref>) and computed tomography (CT) of the brain on day 7 showed no abnormality. However, his condition continued to deteriorate, and a repeat MRI on day 14 revealed a well-defined lesion in the pons of low T1 signal intensity (<xref ref-type="fig" rid="F2">Fig. 2</xref>) as well as a lesion of high T2 signal intensity (<xref ref-type="fig" rid="F3">Fig. 3</xref>). A diagnosis of central pontine myelinolysis (CPM) was made.</p>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>T1 weighted MR image of the brain</p>
      </caption>
      <graphic xlink:href="IJMR-137-993-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>Brain MRI of the patient showing a low T1 signal intensity lesion (day 14).</p>
      </caption>
      <graphic xlink:href="IJMR-137-993-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>T2 - weighted image of hyperintensity in the pons (black arrow) consistent with CPM (day 14).</p>
      </caption>
      <graphic xlink:href="IJMR-137-993-g003"/>
    </fig>
    <p>CPM is an subacute demyelinating condition of the brain stem and a recognized complication of the treatment of patients with chronic hyponatremia (&gt;48 h)<xref ref-type="bibr" rid="ref1">1</xref>. The risk of CPM is believed to be associated with a rapid (&gt;8 mmol/l/day) correction or overcorrection of the serum sodium concentration. However, there is no accepted safe rate of correction<xref ref-type="bibr" rid="ref2">2</xref>. Conventional imaging findings (MRI and CT) lag behind clinical manifestations, thus limiting the utility of imaging in early diagnosis. Imaging is advocated later to confirm CPM diagnosis<xref ref-type="bibr" rid="ref3">3</xref>. There are no effective therapeutic methods for CPM treatment and recovery varies ranging from none to substantial improvement<xref ref-type="bibr" rid="ref4">4</xref>. Although the use of plasmapheresis (PP) and immunoglobulins (IVIg) has been reported in analogous situations, support for their use in the liver transplant population is limited but, there is no clear evidence as to why PP and IVIG may help reverse the neurologic sequelae of CPM. However, it has been suggested that the initial osmotic stress results in the release of myelinotoxic products that can lead to demyelination<xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref7">7</xref>.</p>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Senzolo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ferronato</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Burra</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Neurologic complications after solid organ transplantation</article-title>
          <source>Transpl Int</source>
          <year>2009</year>
          <volume>22</volume>
          <fpage>269</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="pmid">19076332</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adrogu&#xE9;</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Madias</surname>
              <given-names>NE</given-names>
            </name>
          </person-group>
          <article-title>Hyponatremia</article-title>
          <source>N Engl J Med</source>
          <year>2000</year>
          <volume>342</volume>
          <fpage>1581</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">10824078</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laureno</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Illo</surname>
              <given-names>wsky Karp B</given-names>
            </name>
          </person-group>
          <article-title>Myelinolysis after correction of hyponatremia</article-title>
          <source>Ann Intern Med</source>
          <year>1997</year>
          <volume>126</volume>
          <fpage>57</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">8992924</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Menger</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>J&#xF6;rg</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Outcome of central pontine and extrapontine myelinolysis (n = 44)</article-title>
          <source>J Neurol</source>
          <year>1999</year>
          <volume>246</volume>
          <fpage>700</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">10460448</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bibl</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lampl</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jungling</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Brock</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kostler</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Treatment of central pontine myelinolysis with therapeutic plasmapheresis</article-title>
          <source>Lancet</source>
          <year>1999</year>
          <volume>353</volume>
          <fpage>1155</fpage>
          <pub-id pub-id-type="pmid">10209986</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finsterer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Engelmayer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Trnka</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stiskal</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Immunoglobulins are effective in pontine myelinolysis</article-title>
          <source>Clin Neuropharmacol</source>
          <year>2000</year>
          <volume>23</volume>
          <fpage>110</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">10803802</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saner</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Koeppen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kohnle</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Herget-Rosenthal</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sotiropoulos</surname>
              <given-names>GC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Treatment of central pontine myelinolysis with plasmapheresis and immunoglobulins in liver transplant patient</article-title>
          <source>Transpl Int</source>
          <year>2008</year>
          <volume>21</volume>
          <fpage>390</fpage>
          <lpage>1</lpage>
          <pub-id pub-id-type="pmid">18069924</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
